EAST HANOVER, NJ — March 28, 2002 – Elidel® (pimecrolimus) Cream 1% significantly improved the signs and symptoms of eczema, particularly in the head and neck regions.
These data were published in the April issue of the Journal of the American Academy of Dermatology.
Elidel, a new non-steroid prescription cream for the treatment of mild to moderate eczema in patients age two and older, was recently made available in the United States.
"Traditionally it's been difficult to treat the head and neck regions due to concerns over side effects with using corticosteroids on these sensitive areas. These data underscore the safety and efficacy of using Elidel on these most sensitive skin areas," said Dr. Lawrence Eichenfield, chief of pediatric and adolescent dermatology, Children's Hospital, San Diego, Califorina, and lead author of the study. "Having a well-tolerated, steroid-free treatment available that can be safely used on all skin surfaces is an important advance in the treatment of this disease."